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15% respectively whereas 7% had both the integrons. Transferabil-
ity of PMQR genes to transconjugantswas conﬁrmed. Interestingly,
neither the ﬂuoroquinolone consumption in the hospital nor the
frequency of PMQR isolates varied much in the four years of the
study.
Conclusion: Only three strains with MIC >256g/mL were
PMQR-negative. The frequency of PMQR genes among the bacte-
rial population studied is higher than reported elsewhere. Notably,
all the ciproﬂoxacin-resistant Escherichia coli carried PMQR genes.
The presence of PMQR gene in Providencia rettgeri has not been
reported before. Finally, this study reports the single mutant vari-
ant of aac(6’)-Ib gene for the ﬁrst time from the clinical isolates. To
conclude there is a need for rational usage of ﬂuoroquinolones and
reconsideration of their clinical breakpoints.
Pair-wise distance matrix analysis of acc(6’)-Ib-cr gene.
http://dx.doi.org/10.1016/j.ijid.2016.02.300
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Background: From the situation analysis on Antimicrobial use
and resistance in Kenya 2011, 50% of the leading causes of death
in Kenya are due to infectious diseases and antimicrobial resis-
tance tomicrobes indicated rising trendsof resistance to commonly
used antibiotics (66%, 94%, 53%, 43% to cotrimoxazole, ampicillin,
ﬂuoroquinolones and penicillins respectively. This is attributed to
inappropriate use of antimicrobials in humans and animals.
Methods & Materials: Desk review of recommendations made
inminutes and reports ofmeetings, conferences andworkshops on
Infection prevention and control and AMR and publications from
studies done in sentinel sites in Kenya.
Results: In 2009 the Global Antibiotic Resistance Partnership
Kenya was established. GARP-K completed and launched a Situa-
tion analysis(SA) of antibiotic use and resistance in Kenya in August
2011; In November 2013- Kenya hosted the ﬁrst Antimicrobial
Resistance (AMR) awareness week and a regional antibiotic stew-
ardship workshop in December 2013 whose recommendations
were submitted to the National Infection Prevention and Control
Committee (NIPCC) at the MOH in Kenya; Following this, ﬁndings
of the SA were disseminated to health managers in 45 counties in
Kenya, InMarch 2014 theNIPCC recommended the appointment of
an AMR focal point; Through the Infection Prevention and Control
Unit the National strategic plan for IPC with two strategic objec-
tives speciﬁc for AMR: establishing a national AMR Surveillance
system and the appointment of National Antimicrobial Steward-
ship Advisory Committee (NASAC);November 2014- during the 2nd
National AMR week the Director of Medical Services established
AMR program and appointed a multisectoral NASAC.
Conclusion: Low interest by leadership on AMR, lack of pri-
oritization and resource allocation by the Ministry of Health for
AMR related activities, changes in the system of governance in the
country following devolution further slowed down the process of
developing national strategies to ﬁght AMR
The AMR program through the leadership of NASAC is in the
process of developing a National Action Plan and policy for AMR
addressing recommendations in the SA and leveraging the inter-
national health regulations and the global health security agenda.
Through the AMR program, revision of the National IPC policy,
guidelines and IPC training curriculumhave included antimicrobial
resistance and antimicrobial stewardship.
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Background: Antimicrobials are one of the most common
medicines prescribed for children. We aimed to describe the
antimicrobial utilization in paediatric wards of a general teaching
hospital and to assess the compliance of this pattern using three
recently introduced guidelines: ChristchurchHospital local antimi-
crobial guideline, the Hospital Medicines List (HML – a national
list of available pharmaceuticals) restrictions and the New Zealand
National Formulary (NZF). The arrival of the Pharmaceutical Man-
agement Agency’s (PHARMAC) HML in July 2013 was the ﬁrst
introduction to a restrictive antimicrobial policy in New Zealand.
NZF provides antibacterial policies which may indicate a range of
drugs for general use, and permit other drugs only on the advice of
the microbiologist or paediatric infectious disease specialist.
Methods & Materials: We conducted a prospective cross-
sectional study of antimicrobial prescriptions over ten weeks
(Oct to Dec, 2013). The audit included all paediatric wards at
Christchurch Hospital, including medical and surgical patients and
inpatients in a national oncology centre. We identiﬁed all chil-
dren receiving antimicrobials and evaluated their prescription for
dosage accuracy, reason of administration, duration of treatment,
and compared these with both local and national guidelines.
Results: A total of 1000 antibiotic prescriptions were issued
for 41 different antibiotics. Overall, 24% (416 out of 1762) of the
children received at least one antibiotic agent during their hospi-
talization. The most commonly prescribed antibiotics were amox-
icillin/clavulanate, amoxicillin, trimethoprim/sulfamethoxazole,
